Jury Finds Perrigo Infringed Pepcid Patent, Must Pay $10M
A Massachusetts federal jury found Wednesday that pharmaceutical maker Perrigo's generic version of Pepcid Complete antacid infringed a Boston hospital's now-expired patent and awarded the hospital $10.2 million in royalty damages....To view the full article, register now.
Already a subscriber? Click here to view full article